K2M co-founder Dr. John Kostuik sells 46k shares: 6 quick facts

Anuja Vaidya -   Print  |

K2M insider John P. Kostuik, MD, sold 46,957 shares of the company's stock in a transaction on June 18, according to a Mideast Times report.

Here are six quick facts:


1. The shares were sold at an average price of $24.56, for a total value of $1.15 million.


2. Dr. Kostuik now directly owns 190,114 shares in the company, valued at approximately $4.6 million.


3. Dr. Kostuik is a co-founder and CMO of K2M.


4. K2M has a one-year low of $12.31 and a one-year high of $26.29.


5. The stock has a 50-day moving average of $24 and a 200-day moving average of $21.


6. K2M's market cap is $995.34 million.


More articles on devices:
Michael Turpin joins K2M board of directors — 5 key notes
22 things to know about Stryker
FDA grants Centinel Spine allogeneic bone graft indications for lumbar spinal fusion line — 5 key notes

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers